SERAVALLE, GINO LUCIANO
 Distribuzione geografica
Continente #
NA - Nord America 3.976
EU - Europa 1.644
AS - Asia 421
SA - Sud America 15
OC - Oceania 10
AF - Africa 6
Continente sconosciuto - Info sul continente non disponibili 5
Totale 6.077
Nazione #
US - Stati Uniti d'America 3.936
DE - Germania 592
IT - Italia 300
SE - Svezia 278
CN - Cina 212
AT - Austria 94
GB - Regno Unito 86
HK - Hong Kong 72
IE - Irlanda 71
UA - Ucraina 63
VN - Vietnam 51
RU - Federazione Russa 48
CA - Canada 36
IN - India 28
DK - Danimarca 23
BE - Belgio 22
SG - Singapore 22
FR - Francia 21
FI - Finlandia 20
NL - Olanda 12
TR - Turchia 12
BR - Brasile 11
AU - Australia 7
PH - Filippine 5
EU - Europa 4
IR - Iran 4
BG - Bulgaria 3
JP - Giappone 3
KR - Corea 3
MK - Macedonia 3
MX - Messico 3
NZ - Nuova Zelanda 3
TH - Thailandia 3
CL - Cile 2
ES - Italia 2
MU - Mauritius 2
NG - Nigeria 2
PE - Perù 2
RO - Romania 2
SA - Arabia Saudita 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
GR - Grecia 1
HU - Ungheria 1
ID - Indonesia 1
IL - Israele 1
PK - Pakistan 1
TW - Taiwan 1
UG - Uganda 1
ZA - Sudafrica 1
Totale 6.077
Città #
Ann Arbor 877
Frankfurt am Main 540
Fairfield 495
Chandler 316
Wilmington 251
Ashburn 230
Woodbridge 221
Houston 207
Seattle 191
Dearborn 139
Princeton 130
Cambridge 124
Milan 98
Vienna 92
New York 81
Hong Kong 72
Jacksonville 72
Dublin 71
Altamura 58
Lawrence 56
Nanjing 48
Dong Ket 33
San Diego 33
Lissone 23
Brussels 21
Andover 19
Boardman 19
Nanchang 17
London 16
Toronto 16
Kunming 15
Beijing 14
Guangzhou 14
Jiaxing 12
Shenyang 12
Tianjin 10
Hebei 9
Jinan 9
Falls Church 8
Helsinki 8
Shanghai 8
Changsha 7
Edmonton 7
Lachine 7
Sacramento 7
Esslingen am Neckar 6
Monza 6
Norwalk 6
Pune 6
Fremont 5
Fuzhou 5
Kiev 5
Mountain View 5
Chicago 4
Groningen 4
Hangzhou 4
Hounslow 4
Lakeville 4
Lappeenranta 4
Ningbo 4
Ottawa 4
Redmond 4
San Mateo 4
São Paulo 4
Atlanta 3
Brasília 3
Hefei 3
Middle River 3
New Bedfont 3
Owasso 3
Pioltello 3
Taizhou 3
Zhengzhou 3
Ardea 2
Avellino 2
Bergamo 2
Bologna 2
Changchun 2
Chiang Rai 2
Chiswick 2
Cinisello Balsamo 2
Ciudad Valles 2
Dalmine 2
Falkenstein 2
Hanoi 2
Huizen 2
Islington 2
Jeddah 2
Kardzhali 2
Kocaeli 2
Leawood 2
Los Angeles 2
Missaglia 2
Mumbai 2
Romagnano Sesia 2
San Francisco 2
Senago 2
Shiraz 2
Simi Valley 2
Skopje 2
Totale 4.882
Nome #
Sympathetic Neural Overdrive in the Obese and Overweight State: Meta-Analysis of Published Studies 224
Sympathetic and baroreflex alterations in congestive heart failure with preserved, midrange and reduced ejection fraction. 209
Heart rate as cardiovascular risk factor 208
Sympathetic nerve traffic overactivity in chronic kidney disease: a systematic review and meta-analysis 178
Sympathetic overdrive in the metabolic syndrome: meta-analysis of published studies 167
Neuroadrenergic activation in obstructive sleep apnoea syndrome: A new selectedmeta-analysis - revisited 166
Reliability of heart rate as neuroadrenergic marker in the metabolic syndrome. 162
Sympathetic and baroreflex abnormalities in the uncomplicated prediabetic state 160
Evaluation of relationship between cardio-ankle vascular index and 24h ambulatory blood pressure variables 148
Differential effects of enalapril-felodipine versus enalapril-lercanidipine combination drug treatment on sympathetic nerve traffic and metabolic profile in obesity-related hypertension 146
Multicenter Randomized Double-Blind Comparison of Nebivolol plus HCTZ and Irbesartan plus HCTZ in the Treatment of Isolated Systolic Hypertension in Elderly Patients: Results of the NEHIS Study 146
Baroreflex Activation Therapy in Congestive Heart Failure: Novel Findings and Future Insights 141
Follow-up of Antihypertensive Therapy Improves Blood Pressure Control: Results of HYT (HYperTension survey) Follow-up 139
Adding Home and/or Ambulatory Blood Pressure to Office Blood Pressure for Cardiovascular Risk Prediction 133
Response to possible difference in the sympathetic activation on extreme dippers with or without exaggerated morining surge 130
Autonomic Cardiovascular Alterations in Chronic Kidney Disease: Effects of Dialysis, Kidney Transplantation, and Renal Denervation 128
Long-term chronic baroreflex activation: persistent efficacy in patients with heart failure and reduced ejection fraction 123
Sympathetic Nervous System, Hypertension, Obesity and Metabolic Syndrome 122
Within-visit BP variability, cardiovascular risk factors, and BP control in central and eastern Europe: Findings from the BP-CARE study 121
DIFFERING EFFECTS OF RENAL DENERVATION ON BLOOD PRESSURE AND SYMPATHETIC NERVE TRAFFIC: A SYSTEMATIC REVIEW AND META-ANALYSIS 119
Restoration of normal sympathetic neural function in heart failure following baroreflex activation therapy: final 43-month study report 117
Baroreflex activation therapy systems: current status and future prospects 116
Sympathetic neural abnormalities in type 1 and type 2 diabetes: a systematic review and meta-analysis 111
Sympathetic activation in cardiovascular disease: Evidence, clinical impact and therapeutic implications 106
The role of carotid baroreceptor stimulation 103
Effects of Renal Denervation on Sympathetic Nervous System Activity 100
The role of brain in neurogenic prehypertension 100
Effects of chronic carotid baroreceptor activation on arterial stiffness in severe heart failure 100
Sympatho-Vagal Imbalance in Hypertension 98
Limited reliability of heart rate as a sympathetic marker in chronic kidney disease 96
Blood pressure measurement, white-coat and masked hypertension 93
Sympathetic Nervous System, Sleep, and Hypertension 88
Sympathetic nerve traffic and blood pressure changes after bilateral renal denervation in resistant hypertension: A time-integrated analysis 87
Neuroadrenergic activation in obstructive sleep apnea syndrome: a systematic review and meta-analysis 84
Age- and sex-specific reference values for media/lumen ratio in small arteries and relationship with risk factors 83
Heart rate as a predictor of cardiovascular risk 81
Treatment of resistant hypertension 77
Sympathetic Neural Mechanisms Underlying Attended and Unattended Blood Pressure Measurement 75
Assessment of heart rate as 'sympathetic biomarker': Strengths and pitfalls 73
Association between the European Society of Cardiology/European Society of Hypertension Heart Rate Thresholds for Cardiovascular Risk and Neuroadrenergic Markers 69
Cardiopulmonary receptor and arterial baroreceptor reflexes after acute myocardial infarction 68
Role of Sympathetic Nervous System in the Metabolic Syndrome and Sleep Apnea 67
Lercanidipine in the management of hypertension: An update 65
Cigarette smoking and the adrenergic nervous system 63
Obesity and hypertension 61
Neural Mechanisms 60
Neurohormonal interactions 59
Arterial alterations in hypertension 57
Obesity and cardiovascular risk: A call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: Part A: Mechanisms of obesity induced hypertension, diabetes and dyslipidemia and practice guidelines for treatment 56
Sympathetic Nerve Traffic Activation in Essential Hypertension and Its Correlates: Systematic Reviews and Meta-Analyses 53
Targeting persistent normal left ventricular geometry in the general population: a 25-year follow-up study 50
White-Coat Hypertension Without Organ Damage: Impact on Long-Term Mortality, New Hypertension, and New Organ Damage 50
Transient effects of carotid baroreflex stimulation via the neck chamber device on central venous pressure 49
Trained Athletes 48
Cardiovascular physiology: regulation of blood pressure 47
ANTIHYPERTENSIVE DRUG TREATMENT IN WHITE-COAT HYPERTENSION: DATA FROM THE PLAQUE HYPERTENSION LIPID-LOWERING ITALIAN STUDY (PHYLLIS) 45
Iatrogenic Aspects of sports cardiology and lifestyle modifications, Chapter 25: Trained Athletes 45
Baroreceptor Stimulation 43
Sleep Apnea and Hypertension 41
WHITE-COAT HYPERTENSION WITHOUT ORGAN DAMAGE: IMPACT OF LONG-TERM MORTALITY, NEW HYPERTENSION AND NEW ORGAN DAMAGE 41
Corrigendum to “Obesity and hypertension” [Pharmacological Research 122 (2017) 1–7](S1043661817304620)(10.1016/j.phrs.2017.05.013) 39
Autonomic cardiovascular alterations as therapeutic targets in chronic kidney disease 39
Relationships between sympathetic markers and heart rate thresholds for cardiovascular risk in chronic heart failure 36
Sympathetic Overactivation in Patients With Essential Hypertension and Hepatic Iron Overload 36
The Complex Relationship Between Serum Uric Acid, Endothelial Function and Small Vessel Remodeling in Humans 35
Clinical relevance of the sympathetic–vascular interactions in health and disease 35
Microvascular Alterations in Obesity 34
Elevated heart rate as sympathetic biomarker in human obesity 32
The sympathetic nervous system in hypertension 32
Sympathomodulation in congestive heart failure: From drugs to devices 32
Differential effects of renal denervation on skin and muscle sympathetic nerve traffic in resistant and uncontrolled hypertension 26
New-onset aortic dilatation in the population: a quarter-century follow-up 24
Heart rate thresholds for cardiovascular risk and sympathetic activation in the metabolic syndrome 19
Visit-to-visit blood pressure variability is related to sympathetic neural drive and baroreflex sensitivity in hypertensive patients 5
Totale 6.419
Categoria #
all - tutte 18.659
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.659


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019392 0 0 0 0 0 35 42 58 37 38 83 99
2019/2020914 112 43 52 72 72 135 126 76 73 80 51 22
2020/20211.490 106 198 122 113 81 108 160 158 116 115 87 126
2021/2022970 81 87 106 57 75 64 64 56 41 89 77 173
2022/20231.676 169 421 170 135 96 250 65 98 129 44 73 26
2023/2024474 36 38 52 112 158 78 0 0 0 0 0 0
Totale 6.419